Log in
Email Address
Password
Forgot your password?
Not Registered?

Featured Tenants

 cfai

The Centre for Advanced Instrumentation at the NETPark Research Institute collaborates with observatories world-wide in the construction, commissioning and exploitation of innovative hi-tech instruments for optical and infrared astronomy. Key research areas are advanced spectroscopy, adaptive optics, applied optics, low light level detectors and precision engineering/metrology.

Click here to learn more about Centre for Advanced Instrumentation

Featured Opportunity
Provision of value innovation specialist support to SME members of NETPark Net

The aim of this contract is to provide individual and tailored support to members of NETPark Net.  This service is expected to be focused on unlocking innovation within the existing operations of the companies and using this discovered potential to increase turnover and profitability, and create jobs.  For further information click here

The deadline is 11th July 2008

Polls



CDEP logo

cddc   eu

Scientists 'outwit' Aids virus
Bookmark and Share Add This     email Email a Friend    print Printable version

Scientists 'outwit' Aids virus

2008-04-30
Newsfeed

Scientists have found a way of outwitting the HIV Aids virus which gets round the problem of drug resistance that affects existing treatments.


Scientists have found a way of outwitting the HIV Aids virus which gets round the problem of drug resistance that affects existing treatments.

Working in the laboratory, researchers at Boston University in Massachusetts were able to block HIV infection by inactivating a key human protein.

Most drugs used against HIV target the virus's own proteins. But HIV mutates at such a high rate that drug-resistant strains emerge quickly.

Strategies designed to outmanoeuvre the virus such as switching medications and prescribing multiple drugs can increase the risk of side-effects and make life more difficult for the patient.

The new approach targets a protein produced by human cells rather than HIV, and is therefore impervious to the virus's mutations.

Researchers in the US found that inactivating the protein, a signalling molecule that activates T cells known as ITK, suppressed HIV's ability to infect key human immune cells.

When HIV enters the body it enters T cells and takes them over. Instead of defending the body against invaders, the T cells devote themselves to helping the HIV virus replicate. But without active ITK, the virus cannot take advantage of the signalling pathways within T cells it needs to make this happen.

Copyright © The Press Association 2008